Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02364596 · ClinicalTrials.gov registry record · Phase 1
Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years
A Phase 1 study of Staphylococcal Infections, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT02364596: Completed Phase 1 study of Staphylococcal Infections, sponsored by Pfizer.
NCT02364596 is a Phase 1 study of Staphylococcal Infections that has completed, run by Pfizer. The registered enrollment target is 100 participants, below the 263-participant average among 3 other Staphylococcal Infections trials with a reported enrollment target (62% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02364596, a Phase 1 study of Staphylococcal Infections, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and immunogenicity of a single vaccination of an investigational vaccine against Staphylococcus aureus (SA4Ag) in healthy adults aged 18 to \<65 years.
Conditions Studied
Interventions
- BIOLOGICAL SA4Ag vaccine
- PROCEDURE Blood sample
Study Locations (2)
Florida
- Broward Research Group - Hollywood
- Miami Research Associates - South Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-02 |
| Phase | Phase 1 |
What the finished NCT02364596 record still lists
NCT02364596 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 263-participant average among 3 other Staphylococcal Infections trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Staphylococcal Infections appearing as the primary indexed condition, and to 2 interventions - of which SA4Ag vaccine is the first listed.
NCT02364596 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02364596 about?
NCT02364596 is a clinical study titled "Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years". The purpose of this study is to evaluate the safety and immunogenicity of a single vaccination of an investigational vaccine against Staphylococcus aureus (SA4Ag) in healthy adults aged 18 to \<65 years.
What is the current status of trial NCT02364596?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 100 participants. The study started on 2015-01. Estimated completion is 2015-02.
What conditions does trial NCT02364596 study?
This clinical trial studies the following conditions: Staphylococcal Infections.
What interventions are being tested in trial NCT02364596?
The interventions under investigation include: SA4Ag vaccine (BIOLOGICAL), Blood sample (PROCEDURE).
Who is sponsoring clinical trial NCT02364596?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02364596 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Staphylococcal Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine
COMPLETED · Phase 1
-
Modeling Host-Pathogen Interaction Using Lymphoid Organoids
RECRUITING
-
Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia